首页> 外文期刊>Tissue antigens. >HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing
【24h】

HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing

机译:通过长期PCR和高通量测序以超高分辨率水平进行HLA-DRB1,-DRB3,-DRB4和-DRB5基因分型

获取原文
获取原文并翻译 | 示例
       

摘要

Super high-resolution single molecule sequence-based typing (SS-SBT) is a human leukocyte antigen (HLA) DNA typing method to the field 4 level of allelic resolution (formerly known as eight-digit typing) to efficiently detect new and null alleles without phase ambiguity by combination of long ranged polymerase chain reaction (PCR) amplification and next-generation sequencing (NGS) technologies. We previously reported the development and application of the SS-SBT method for the eight classical HLA loci, A, B, C, DRB1, DQA1, DQB1, DPA1 and DPB1. In this article, we describe the development of the SS-SBT method for three DRB1 linked loci, DRB3, DRB4 and DRB5 (DRB3/4/5) and characterization of DRB1-DRB3/4/5 haplotype structures to the field 4 level. Locus specific PCR primers for DRB3/4/5 were designed to amplify the gene regions from intron 1 to exon 6 [3' untranslated region (3'UTR)]. In total 20 DRB1 and 13 DRB3/4/5 allele sequences were determined by the SS-SBT to the field 4 level without phase ambiguity using 19 DR51, DR52 and DR53 positive genomic DNA samples obtained from Japanese. Moreover, 18 DRB1-DRB3/4/5 haplotypes were estimated to the field 4 level by the SS-SBT method in contrast to 10 haplotypes estimated by conventional methods to the field 1 level (formerly known as two digit typing). Therefore, DRB1-DRB3/4/5 haplotyping by SS-SBT is expected to provide informative data for improved HLA matching in medical research, transplantation procedures, HLA-related disease studies and human population diversity studies.
机译:基于超高分辨率单分子序列的分型(SS-SBT)是人类白细胞抗原(HLA)DNA的分型方法,用于等位基因解析的第4级水平(以前称为八位数分型),可以有效地检测新的和无效的等位基因通过将远距离聚合酶链反应(PCR)扩增和下一代测序(NGS)技术相结合,不会产生相位歧义。我们之前曾报道过针对八个经典HLA位点,A,B,C,DRB1,DQA1,DQB1,DPA1和DPB1的SS-SBT方法的开发和应用。在本文中,我们描述了针对三个DRB1连锁位点DRB3,DRB4和DRB5(DRB3 / 4/5)的SS-SBT方法的开发,以及将DRB1-DRB3 / 4/5单倍型结构的特性表征到了领域4的水平。设计用于DRB3 / 4/5的基因座特异性PCR引物,以扩增从内含子1到外显子6的基因区域[3'非翻译区域(3'UTR)]。使用从日本获得的19个DR51,DR52和DR53阳性基因组DNA样本,通过SS-SBT将第20场DRB1和13场DRB3 / 4/5等位基因序列确定为第4场水平,没有相位歧义。此外,通过SS-SBT方法将18种DRB1-DRB3 / 4/5单倍型估计为4级,而通过传统方法将10种单倍型估计为1级(以前称为两位数分型)。因此,SS-SBT的DRB1-DRB3 / 4/5单体型有望为医学研究,移植程序,HLA相关疾病研究和人群多样性研究中改善HLA匹配提供信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号